The FDA has approved GlaxoSmithKline's shingles vaccine Shingrix for use in people aged ... While the immune system can generally shake off the symptoms of chickenpox, the virus lies dormant ...
The new prefilled syringe has the same composition but removes the need for reconstitution. The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new ...
In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shingrix ...
By age 50, VZV is present in most adults and may reactivate with advancing age. Shingrix is a non-live, recombinant subunit vaccine indicated to prevent shingles in adults 50 and over. It combines ...
GSK plc, a global biopharma company, announced that the US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s ...